WHO ICTRP trial
Study for the effect of iodine supplementation during antithyroid drug therapy…
ChiCTR1900028109 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900028109 |
|---|---|
| Public title | Study for the effect of iodine supplementation during antithyroid drug therapy for Graves' disease |
| Scientific title | Study for the effect of iodine supplementation during antithyroid drug therapy for Graves' disease |
| Primary sponsor | The Second Affiliated Hospital of Fujian Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Conditions | Graves’ disease |
| Interventions | Group 1:Iodine supplemented;Group 2:Iodine restricted |
| Registration date | Dec 12, 2019 |
| Target size | Group 1:400;Group 2:400 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: